Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
Publications search results
TitlePublishedTypeProducts
Nitrosamine Reactivity: A Survey of Reactions and Purge ProcessesMirabilis
Developing structure-activity relationships for N-nitrosamine activityDerek Nexus
Supporting more scientifically driven risk assessments under ICH Q3Dpdf fileElemental Impurities
Introduction to ICH Q3D guidance_The move from heavy metal testing to ICH Q3Dpdf fileElemental Impurities
Supporting more scientifically driven risk assessments under ICH Q3D: Elemental Impurities Data Sharing_Webinar RecordingElemental Impurities
Employing an adverse outcome pathway framework for weight-of-evidence assessment with application to the ICH S1B guidance addendumKaptis
ICH Q3D Drug Product Elemental Risk Assessment: The use of an elemental impurities excipients databaseElemental Impurities
Automated chromophore identification to support prediction of light-mediated reactivitypdf fileZeneth
Structural features affecting nitrosamine carcinogenic potencypdf file
In Silico Prediction of Genotoxicity Current Applications and Future Perspectivespdf fileDerek NexusSarah Nexus
Resolving conflicting data sources to a single call in Sarah Nexus [an infographic]pdf fileSarah Nexus
Zeneth Member Type Infographicpdf fileZeneth
Could the Lhasa Cloud be the best hosting option for you? (Infographic)pdf fileMirabilisViticKaptis
2021 Webinar | Accessing vital sources of long-term carcinogenicity study data with Lhasa’s Carcinogenicity Database – An update and an overview - RecordingLhasa Carcinogenicity Database
2021 Webinar | Accessing vital sources of long-term carcinogenicity study data with Lhasa’s Carcinogenicity Database – An update and an overview - Slidespdf fileLhasa Carcinogenicity Database
Predicting N-Nitrosamine Activity from SARpdf fileDerek NexusSarah NexusLhasa Carcinogenicity DatabaseNitrites in Excipients
QSAR 2021 Addressing the global challenge of N-nitrosamine impurity assessmentpdf fileDerek NexusMirabilisSarah NexusVitic
QSAR 2021 - leveraging data from multiple sources to build QSARs through curation and federated learning in Effiris.pdf fileEffiris
QSAR 2021 Is the bacterial reverse mutation assay an accurate predictor for N-nitrosamine carcinogenicitypdf fileVitic
Effiris_Improving in silico secondary pharmacology profiling using federated QSAR modelspdf fileEffiris
Managing the risk of nitrosamine impurities
Quantifying the nitrosamine potency distributionpdf fileLhasa Carcinogenicity Database
A collaborative benchmarking study to evaluate the newly released Zeneth 8pdf fileZeneth
In silico prediction of N-nitrosamine degradants in APIs that possess a secondary or tertiary amine functional grouppdf fileZeneth
1. Qualifying impurities and degradation products: Anvisa's experience and technical improvement - Maria Rodrigues (Slides)pdf file

© 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.